297 related articles for article (PubMed ID: 22739568)
1. Etodolac blocks the allyl isothiocyanate-induced response in mouse sensory neurons by selective TRPA1 activation.
Inoue N; Ito S; Nogawa M; Tajima K; Kyoi T
Pharmacology; 2012; 90(1-2):47-54. PubMed ID: 22739568
[TBL] [Abstract][Full Text] [Related]
2. Etodolac activates and desensitizes transient receptor potential ankyrin 1.
Wang S; Dai Y; Kogure Y; Yamamoto S; Zhang W; Noguchi K
J Neurosci Res; 2013 Dec; 91(12):1591-8. PubMed ID: 24027177
[TBL] [Abstract][Full Text] [Related]
3. Cold sensitivity of recombinant TRPA1 channels.
Sawada Y; Hosokawa H; Hori A; Matsumura K; Kobayashi S
Brain Res; 2007 Jul; 1160():39-46. PubMed ID: 17588549
[TBL] [Abstract][Full Text] [Related]
4. Activation of transient receptor potential ankyrin 1 evokes nociception through substance P release from primary sensory neurons.
Nakamura Y; Une Y; Miyano K; Abe H; Hisaoka K; Morioka N; Nakata Y
J Neurochem; 2012 Mar; 120(6):1036-47. PubMed ID: 22182301
[TBL] [Abstract][Full Text] [Related]
5. A novel 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime compound is a potent Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and V1) receptor antagonist.
Payrits M; Sághy É; Mátyus P; Czompa A; Ludmerczki R; Deme R; Sándor Z; Helyes Z; Szőke É
Neuroscience; 2016 Jun; 324():151-62. PubMed ID: 26930003
[TBL] [Abstract][Full Text] [Related]
6. TRPA1 and TRPV1 activation is a novel adjuvant effect mechanism in contact hypersensitivity.
Shiba T; Maruyama T; Kurohane K; Iwasaki Y; Watanabe T; Imai Y
J Neuroimmunol; 2009 Feb; 207(1-2):66-74. PubMed ID: 19135264
[TBL] [Abstract][Full Text] [Related]
7. Miogadial and miogatrial with alpha,beta-unsaturated 1,4-dialdehyde moieties--novel and potent TRPA1 agonists.
Iwasaki Y; Tanabe M; Kayama Y; Abe M; Kashio M; Koizumi K; Okumura Y; Morimitsu Y; Tominaga M; Ozawa Y; Watanabe T
Life Sci; 2009 Jul; 85(1-2):60-9. PubMed ID: 19409911
[TBL] [Abstract][Full Text] [Related]
8. Contractile effect of TRPA1 receptor agonists in the isolated mouse intestine.
Penuelas A; Tashima K; Tsuchiya S; Matsumoto K; Nakamura T; Horie S; Yano S
Eur J Pharmacol; 2007 Dec; 576(1-3):143-50. PubMed ID: 17825279
[TBL] [Abstract][Full Text] [Related]
9. Activation of transient receptor potential ankyrin 1 by eugenol.
Chung G; Im ST; Kim YH; Jung SJ; Rhyu MR; Oh SB
Neuroscience; 2014 Mar; 261():153-60. PubMed ID: 24384226
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of human transient receptor potential M5 upregulates endogenous human transient receptor potential A1 in a stable HEK cell line.
Buber MT; Cerne R; Cortés RY; Bryant RW; Lee SP
Assay Drug Dev Technol; 2010 Dec; 8(6):695-702. PubMed ID: 21133676
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous nociception evoked by 15-delta PGJ2 via activation of ion channel TRPA1.
Cruz-Orengo L; Dhaka A; Heuermann RJ; Young TJ; Montana MC; Cavanaugh EJ; Kim D; Story GM
Mol Pain; 2008 Jul; 4():30. PubMed ID: 18671867
[TBL] [Abstract][Full Text] [Related]
12. Contribution of TRPV1 to the bradykinin-evoked nociceptive behavior and excitation of cutaneous sensory neurons.
Katanosaka K; Banik RK; Giron R; Higashi T; Tominaga M; Mizumura K
Neurosci Res; 2008 Nov; 62(3):168-75. PubMed ID: 18789982
[TBL] [Abstract][Full Text] [Related]
13. Propofol restores transient receptor potential vanilloid receptor subtype-1 sensitivity via activation of transient receptor potential ankyrin receptor subtype-1 in sensory neurons.
Zhang H; Wickley PJ; Sinha S; Bratz IN; Damron DS
Anesthesiology; 2011 May; 114(5):1169-79. PubMed ID: 21364461
[TBL] [Abstract][Full Text] [Related]
14. H(2)S functions as a nociceptive messenger through transient receptor potential ankyrin 1 (TRPA1) activation.
Ogawa H; Takahashi K; Miura S; Imagawa T; Saito S; Tominaga M; Ohta T
Neuroscience; 2012 Aug; 218():335-43. PubMed ID: 22641084
[TBL] [Abstract][Full Text] [Related]
15. Transient receptor potential ankyrin 1 activation enhances hapten sensitization in a T-helper type 2-driven fluorescein isothiocyanate-induced contact hypersensitivity mouse model.
Shiba T; Tamai T; Sahara Y; Kurohane K; Watanabe T; Imai Y
Toxicol Appl Pharmacol; 2012 Nov; 264(3):370-6. PubMed ID: 22935519
[TBL] [Abstract][Full Text] [Related]
16. TRPA1 expression levels and excitability brake by K
Memon T; Chase K; Leavitt LS; Olivera BM; Teichert RW
Neuroscience; 2017 Jun; 353():76-86. PubMed ID: 28408328
[TBL] [Abstract][Full Text] [Related]
17. The anti-diabetic drug glibenclamide is an agonist of the transient receptor potential Ankyrin 1 (TRPA1) ion channel.
Babes A; Fischer MJ; Filipovic M; Engel MA; Flonta ML; Reeh PW
Eur J Pharmacol; 2013 Mar; 704(1-3):15-22. PubMed ID: 23461853
[TBL] [Abstract][Full Text] [Related]
18. Activation of TRPA1 channels by the fatty acid amide hydrolase inhibitor 3'-carbamoylbiphenyl-3-yl cyclohexylcarbamate (URB597).
Niforatos W; Zhang XF; Lake MR; Walter KA; Neelands T; Holzman TF; Scott VE; Faltynek CR; Moreland RB; Chen J
Mol Pharmacol; 2007 May; 71(5):1209-16. PubMed ID: 17314320
[TBL] [Abstract][Full Text] [Related]
19. TRPA1 receptor localisation in the human peripheral nervous system and functional studies in cultured human and rat sensory neurons.
Anand U; Otto WR; Facer P; Zebda N; Selmer I; Gunthorpe MJ; Chessell IP; Sinisi M; Birch R; Anand P
Neurosci Lett; 2008 Jun; 438(2):221-7. PubMed ID: 18456404
[TBL] [Abstract][Full Text] [Related]
20. The peptide Phα1β, from spider venom, acts as a TRPA1 channel antagonist with antinociceptive effects in mice.
Tonello R; Fusi C; Materazzi S; Marone IM; De Logu F; Benemei S; Gonçalves MC; Coppi E; Castro-Junior CJ; Gomez MV; Geppetti P; Ferreira J; Nassini R
Br J Pharmacol; 2017 Jan; 174(1):57-69. PubMed ID: 27759880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
